Organigram Global (OGI) Asset Utilization Ratio (2019 - 2026)

Organigram Global (OGI) posted quarterly Asset Utilization Ratio of 0.67 for Q1 2026, up 20.68% quarter-over-quarter from 0.55 in Q4 2025.

Organigram Global (OGI) Asset Utilization Ratio (2019 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Asset Utilization Ratio for 5 consecutive years, with 0.67 the latest figure, recorded in Q1 2026.

In Q1 2026, Asset Utilization Ratio changed N/A year-over-year to 0.67; the TTM figure through Mar 2026 stood at 0.67 (changed N/A YoY), while the FY2025 annual figure was 0.51, changed N/A from the prior year.
Asset Utilization Ratio grew to 0.67 in Q1 2026 per OGI's latest filing, from 0.55 in the prior quarter.
Across five years, Asset Utilization Ratio topped out at 0.67 in Q1 2026 and bottomed at 0.55 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-	-
2	Teva Pharmaceutical Industries	43.28 Bn	39.62 Bn	2.15 Bn	0.43
3	Zoetis	31.79 Bn	30.11 Bn	1.05 Bn	0.63
4	Takeda Pharmaceutical	28.69 Bn	22.89 Bn	5.10 Bn	0.47
5	United Therapeutics	22.25 Bn	19.58 Bn	683.80 Mn	0.45
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	0.41
7	Neurocrine Biosciences	15.58 Bn	15.19 Bn	935.80 Mn	0.66
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn	0.37
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	-
10	Organigram Global	150.66 Mn	150.54 Mn	28.97 Mn	0.67

Download Data